428 related articles for article (PubMed ID: 30689086)
21. Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment.
MaassenVanDenBrink A; Terwindt GM; van den Maagdenberg AMJM
Genome Med; 2018 Feb; 10(1):10. PubMed ID: 29471874
[TBL] [Abstract][Full Text] [Related]
22. Erenumab in the treatment of migraine.
Jain S; Yuan H; Spare N; Silberstein SD
Pain Manag; 2018 Nov; 8(6):415-426. PubMed ID: 30235976
[TBL] [Abstract][Full Text] [Related]
23. Effects of monoclonal antagonist antibodies on calcitonin gene-related peptide receptor function and trafficking.
Manoukian R; Sun H; Miller S; Shi D; Chan B; Xu C
J Headache Pain; 2019 Apr; 20(1):44. PubMed ID: 31039731
[TBL] [Abstract][Full Text] [Related]
24. Calcitonin gene-related peptide (CGRP) antagonists and migraine: is this a new era?
Goadsby PJ
Neurology; 2008 Apr; 70(16):1300-1. PubMed ID: 18413584
[No Abstract] [Full Text] [Related]
25. The CGRP Pathway in Migraine as a Viable Target for Therapies.
Edvinsson L
Headache; 2018 May; 58 Suppl 1():33-47. PubMed ID: 29697153
[TBL] [Abstract][Full Text] [Related]
26. CGRP receptor antagonists for migraine. Are they also AMY
Garelja ML; Walker CS; Hay DL
Br J Pharmacol; 2022 Feb; 179(3):454-459. PubMed ID: 34076887
[TBL] [Abstract][Full Text] [Related]
27. Eptinezumab: First Approval.
Dhillon S
Drugs; 2020 May; 80(7):733-739. PubMed ID: 32266704
[TBL] [Abstract][Full Text] [Related]
28. CGRP mechanism antagonists and migraine management.
Karsan N; Goadsby PJ
Curr Neurol Neurosci Rep; 2015 May; 15(5):25. PubMed ID: 25790955
[TBL] [Abstract][Full Text] [Related]
29. Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.
Pellesi L; Guerzoni S; Pini LA
Clin Pharmacol Drug Dev; 2017 Nov; 6(6):534-547. PubMed ID: 28409893
[TBL] [Abstract][Full Text] [Related]
30. CGRP receptor antagonists: toward a novel migraine therapy.
Salvatore CA; Kane SA
Curr Pharm Biotechnol; 2011 Oct; 12(10):1671-80. PubMed ID: 21466447
[TBL] [Abstract][Full Text] [Related]
31. Targeting CGRP via receptor antagonism and antibody neutralisation in two distinct rodent models of migraine-like pain.
Christensen SL; Petersen S; Kristensen DM; Olesen J; Munro G
Cephalalgia; 2019 Dec; 39(14):1827-1837. PubMed ID: 31288556
[TBL] [Abstract][Full Text] [Related]
32. Anti-CGRP and anti-CGRP receptor monoclonal antibodies as antimigraine agents. Potential differences in safety profile postulated on a pathophysiological basis.
Tringali G; Navarra P
Peptides; 2019 Jun; 116():16-21. PubMed ID: 31018157
[TBL] [Abstract][Full Text] [Related]
33. Blocking the CGRP Pathway for Acute and Preventive Treatment of Migraine: The Evolution of Success.
Dubowchik GM; Conway CM; Xin AW
J Med Chem; 2020 Jul; 63(13):6600-6623. PubMed ID: 32058712
[TBL] [Abstract][Full Text] [Related]
34. Beyond CGRP: The calcitonin peptide family as targets for migraine and pain.
Rees TA; Hendrikse ER; Hay DL; Walker CS
Br J Pharmacol; 2022 Feb; 179(3):381-399. PubMed ID: 34187083
[TBL] [Abstract][Full Text] [Related]
35. Gender aspects of CGRP in migraine.
Labastida-Ramírez A; Rubio-Beltrán E; Villalón CM; MaassenVanDenBrink A
Cephalalgia; 2019 Mar; 39(3):435-444. PubMed ID: 29082826
[TBL] [Abstract][Full Text] [Related]
36. Antigens and Antibodies in Disease With Specifics About CGRP Immunology.
Taylor FR
Headache; 2018 Nov; 58 Suppl 3():230-237. PubMed ID: 30187471
[TBL] [Abstract][Full Text] [Related]
37. CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
Favoni V; Giani L; Al-Hassany L; Asioli GM; Butera C; de Boer I; Guglielmetti M; Koniari C; Mavridis T; Vaikjärv M; Verhagen I; Verzina A; Zick B; Martelletti P; Sacco S;
J Headache Pain; 2019 Mar; 20(1):27. PubMed ID: 30866804
[TBL] [Abstract][Full Text] [Related]
38. CGRP Monoclonal Antibodies for Migraine: Rationale and Progress.
Yuan H; Lauritsen CG; Kaiser EA; Silberstein SD
BioDrugs; 2017 Dec; 31(6):487-501. PubMed ID: 29116598
[TBL] [Abstract][Full Text] [Related]
39. CGRP Discovery and Timeline.
Arkless K; Argunhan F; Brain SD
Handb Exp Pharmacol; 2019; 255():1-12. PubMed ID: 30430259
[TBL] [Abstract][Full Text] [Related]
40. Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.
Goadsby PJ
Drugs; 2005; 65(18):2557-67. PubMed ID: 16392873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
